135 related articles for article (PubMed ID: 16037310)
1. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
2. The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals.
Conner JR; Beisswenger PJ; Szwergold BS
Biochem Biophys Res Commun; 2004 Oct; 323(3):932-6. PubMed ID: 15381090
[TBL] [Abstract][Full Text] [Related]
3. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
Szwergold BS
Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
[TBL] [Abstract][Full Text] [Related]
4. Fructosamine-3-kinase-related-protein phosphorylates glucitolamines on the C-4 hydroxyl: novel substrate specificity of an enigmatic enzyme.
Szwergold B; Manevich Y; Payne L; Loomes K
Biochem Biophys Res Commun; 2007 Oct; 361(4):870-5. PubMed ID: 17686456
[TBL] [Abstract][Full Text] [Related]
5. The physiological substrates of fructosamine-3-kinase-related-protein (FN3KRP) are intermediates of nonenzymatic reactions between biological amines and ketose sugars (fructation products).
Szwergold BS; Bunker RD; Loomes KM
Med Hypotheses; 2011 Nov; 77(5):739-44. PubMed ID: 21924559
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
Payne LS; Brown PM; Middleditch M; Baker E; Cooper GJ; Loomes KM
Biochem J; 2008 Dec; 416(2):281-8. PubMed ID: 18637789
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of fructosamine 3 kinase in patients with colorectal cancer.
Caruso MG; Notarnicola M; Altomare DF; Misciagna G
Oncology; 2007; 73(1-2):72-5. PubMed ID: 18334852
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic repair of Amadori products.
Van Schaftingen E; Collard F; Wiame E; Veiga-da-Cunha M
Amino Acids; 2012 Apr; 42(4):1143-50. PubMed ID: 20967558
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
10. Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.
Gemayel R; Fortpied J; Rzem R; Vertommen D; Veiga-da-Cunha M; Van Schaftingen E
FEBS J; 2007 Sep; 274(17):4360-74. PubMed ID: 17681011
[TBL] [Abstract][Full Text] [Related]
11. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.
Delplanque J; Delpierre G; Opperdoes FR; Van Schaftingen E
J Biol Chem; 2004 Nov; 279(45):46606-13. PubMed ID: 15331600
[TBL] [Abstract][Full Text] [Related]
13. A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines.
Szwergold B
Rejuvenation Res; 2021 Aug; 24(4):310-318. PubMed ID: 34314247
[TBL] [Abstract][Full Text] [Related]
14. Increased protein glycation in fructosamine 3-kinase-deficient mice.
Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
[TBL] [Abstract][Full Text] [Related]
15. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
Szwergold BS; Howell S; Beisswenger PJ
Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
[TBL] [Abstract][Full Text] [Related]
16. Regulation of surfactant protein B gene expression in bone marrow-derived cells.
Field-Corbett C; English K; O'Dea S
Stem Cells; 2009 Mar; 27(3):662-9. PubMed ID: 19096034
[TBL] [Abstract][Full Text] [Related]
17. Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.
Fortpied J; Gemayel R; Stroobant V; van Schaftingen E
Biochem J; 2005 Jun; 388(Pt 3):795-802. PubMed ID: 15705060
[TBL] [Abstract][Full Text] [Related]
18. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia.
You B; Ren A; Yan G; Sun J
Diabetes; 2007 May; 56(5):1445-53. PubMed ID: 17325258
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300.
Kaur H; Chen S; Xin X; Chiu J; Khan ZA; Chakrabarti S
Diabetes; 2006 Nov; 55(11):3104-11. PubMed ID: 17065349
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
